Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells

被引:34
作者
Kumakura, S
Tsutsui, TW
Yagisawa, J
Barrett, JC
Tsutsui, T
机构
[1] NCI, Ctr Canc Res, Lab Biosyst & Canc, NIH, Bethesda, MD 20892 USA
[2] Nippon Dent Univ Tokyo, Dept Pharmacol, Sch Dent, Tokyo, Japan
关键词
D O I
10.1158/0008-5472.CAN-04-1819
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immortal cell lines and tumors maintain their telomeres via the telomerase pathway or via a telomerase-independent pathway, referred to as alternative lengthening of telomeres (ALT). Here, we show the reversible conversion of the human papillomavirus type 16 E6-induced immortal human fibroblasts E6 CI 6 from telomerase-positive (Tel(+)) to telomerasenegative (Tel(-)) cells. Tel(+) cells converted spontaneously to Tel(-)cells that reverted to Tel(+) cells following treatment with trichostatin A (TSA) and/or 5-aza-2'-deoxycytidine (5-AZC), which induced the reversion from complete to partial methylation of the CpG islands of the human telomerase reverse transcriptase (hTERT) promoter in Tel- E6 Cl 6 cells. Tel- E6 Cl 6 cells lacked the phenotypes characteristic of ALT cell lines such as very long and heterogenous telomeres and ALT-associated promyelocytic leukemia nuclear bodies (APB) but grew for > 240 population doublings (PD) after they became telomerase negative. The ratios of histone H3 (113) lysine (K) 9 methylation to each of H3-K4 methylnation, H3-K9 acetylation, and H3-KI4 acetylation of the chromatin containing the hTERT promoter in Tel- E6 Cl 6 cells and ALT cell lines were greater than those in Tel(+) cells and decreased following treatment with TSA and/or 5-AZC, inversely corresponding to telomerase activity. Our findings suggest the possibility that human tumors may be able to reversibly interconvert their telomere maintenance phenotypes by chromatin structure-mediated regulation of hTERT expression.
引用
收藏
页码:2778 / 2786
页数:9
相关论文
共 34 条
[11]   Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway [J].
Grobelny, JV ;
Kulp-McEliece, M ;
Broccoli, D .
HUMAN MOLECULAR GENETICS, 2001, 10 (18) :1953-1961
[12]   Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres [J].
Guilleret, I ;
Benhattar, J .
EXPERIMENTAL CELL RESEARCH, 2003, 289 (02) :326-334
[13]   TELOMERES SHORTEN DURING AGING OF HUMAN FIBROBLASTS [J].
HARLEY, CB ;
FUTCHER, AB ;
GREIDER, CW .
NATURE, 1990, 345 (6274) :458-460
[14]  
Hoare SF, 2001, CANCER RES, V61, P27
[15]   Telomere length and telomerase activity in the process of human fibroblast immortalization [J].
S. Kumakura ;
A. Yamamoto ;
J. Yagisawa ;
M. Uchida ;
T. Tsutsui .
Odontology, 2002, 90 (1) :0013-0021
[16]   Multiple tumor suppressor pathways negatively regulate telomerase [J].
Lin, SY ;
Elledge, SJ .
CELL, 2003, 113 (07) :881-889
[17]   NEOPLASTIC TRANSFORMATION OF HUMAN-DIPLOID FIBROBLASTS (KMST-6) BY TREATMENT WITH CO-60 GAMMA-RAYS [J].
NAMBA, M ;
NISHITANI, K ;
HYODOH, F ;
FUKUSHIMA, F ;
KIMOTO, T .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (02) :275-280
[18]  
Nguyen CT, 2002, CANCER RES, V62, P6456
[19]   Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase [J].
Ouellette, MM ;
Liao, M ;
Herbert, BS ;
Johnson, M ;
Holt, SE ;
Liss, HS ;
Shay, JW ;
Wright, WE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10072-10076
[20]   Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids [J].
Perrem, K ;
Bryan, TM ;
Englezou, A ;
Hackl, T ;
Moy, EL ;
Reddel, RR .
ONCOGENE, 1999, 18 (22) :3383-3390